Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 4 studies | 42% ± 17% | |
retinal cone cell | 3 studies | 31% ± 7% | |
retinal rod cell | 3 studies | 19% ± 2% | |
GABAergic neuron | 3 studies | 43% ± 11% | |
neuron | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 659.40 | 180 / 180 | 100% | 6.34 | 430 / 430 |
brain | 100% | 1932.12 | 2640 / 2642 | 100% | 18.90 | 705 / 705 |
breast | 100% | 592.47 | 459 / 459 | 100% | 8.45 | 1113 / 1118 |
prostate | 100% | 504.51 | 244 / 245 | 100% | 7.07 | 501 / 502 |
thymus | 100% | 544.97 | 651 / 653 | 100% | 8.69 | 602 / 605 |
adrenal gland | 100% | 708.68 | 258 / 258 | 99% | 15.69 | 228 / 230 |
uterus | 100% | 579.42 | 170 / 170 | 98% | 6.15 | 449 / 459 |
esophagus | 99% | 601.85 | 1435 / 1445 | 98% | 5.03 | 180 / 183 |
lung | 98% | 462.65 | 569 / 578 | 99% | 5.81 | 1141 / 1155 |
kidney | 100% | 545.74 | 89 / 89 | 96% | 5.79 | 866 / 901 |
bladder | 100% | 540.38 | 21 / 21 | 96% | 4.99 | 482 / 504 |
liver | 100% | 553.37 | 225 / 226 | 96% | 5.64 | 388 / 406 |
skin | 98% | 473.16 | 1780 / 1809 | 96% | 8.38 | 454 / 472 |
intestine | 93% | 537.15 | 897 / 966 | 89% | 3.43 | 468 / 527 |
stomach | 92% | 405.22 | 329 / 359 | 90% | 3.71 | 256 / 286 |
pancreas | 70% | 174.13 | 228 / 328 | 97% | 5.09 | 172 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 3.91 | 29 / 29 |
muscle | 100% | 1213.28 | 803 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 5.40 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.53 | 1 / 1 |
blood vessel | 100% | 779.37 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 582.58 | 1202 / 1204 | 0% | 0 | 0 / 0 |
spleen | 99% | 345.43 | 238 / 241 | 0% | 0 | 0 / 0 |
heart | 91% | 602.57 | 785 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 78% | 4.00 | 62 / 80 |
peripheral blood | 21% | 134.60 | 192 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032484 | Biological process | Ral protein signal transduction |
GO_0010803 | Biological process | regulation of tumor necrosis factor-mediated signaling pathway |
GO_0043129 | Biological process | surfactant homeostasis |
GO_0043124 | Biological process | negative regulation of canonical NF-kappaB signal transduction |
GO_0048286 | Biological process | lung alveolus development |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005525 | Molecular function | GTP binding |
GO_0032794 | Molecular function | GTPase activating protein binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | NKIRAS1 |
Protein name | NF-kappa-B inhibitor-interacting Ras-like protein 1 (I-kappa-B-interacting Ras-like protein 1) (Kappa B-Ras protein 1) (KappaB-Ras1) NFKB inhibitor interacting Ras like 1 (NFKB inhibitor interacting Ras-like 1, isoform CRA_a) |
Synonyms | KBRAS1 hCG_1778083 |
Description | FUNCTION: Atypical Ras-like protein that acts as a potent regulator of NF-kappa-B activity by preventing the degradation of NF-kappa-B inhibitor beta (NFKBIB) by most signals, explaining why NFKBIB is more resistant to degradation. May act by blocking phosphorylation of NFKBIB and mediating cytoplasmic retention of p65/RELA NF-kappa-B subunit. It is unclear whether it acts as a GTPase. Both GTP- and GDP-bound forms block phosphorylation of NFKBIB. . |
Accessions | ENST00000412028.5 G5E9P3 ENST00000388759.7 ENST00000437230.5 Q9NYS0 ENST00000415901.6 ENST00000421515.6 ENST00000614374.4 ENST00000443659.6 ENST00000416026.2 ENST00000425478.7 |